MA vs TNGX · P/E 38, rev $17.68B vs $5.36B cap
Mastercard Inc (MA) versus Tango Therapeutics Inc (TNGX) — a side-by-side from cached financials, not a winner call.
Mastercard Inc (MA) is a credit services company listed on US. It is led by Michael Miebach.
Tango Therapeutics Inc (TNGX) is a biotechnology company listed on NASDAQ.
Latest reported MA revenue for 2026-06-30 was $17.68B. Net income was $8.27B. MA currently screens at market cap $515.12B and trailing P/E 38.4.
Latest reported TNGX revenue for 2026-06-30 was $0. Net income was -$100.9M. TNGX currently screens at market cap $5.36B.
MA currently screens at market cap $515.12B and trailing P/E 38.4. TNGX currently screens at market cap $5.36B.
Not investment advice. Open the MA and TNGX stock pages for the full models.
Not investment advice.